TNF-α in Uveitis: From Bench to Clinic

TNF-α in Uveitis: From Bench to Clinic

Uveitis is an inflammation of the iris, ciliary body, vitreous, retina, or choroid, which has been shown to be the first manifestation of numerous systemic diseases. Studies about the immunopathogenesis and treatment of uveitis are helpful to comprehend systemic autoimmune diseases, and delay the pr...

Full description

Bibliographic Details
Main Authors:	Qi Jiang, Zhaohuai Li, Tianyu Tao, Runping Duan, Xianggui Wang, Wenru Su
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Pharmacology
Subjects:	uveitis TNF-α anti-TNF-α agents infliximab adalimumab golimumab
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.740057/full

Similar Items

Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
by: Biao Li, et al.
Published: (2023-07-01)

Uveitis in Children: The Role of Biological Agents in Its Management
by: Jamel Corredores, et al.
Published: (2023-02-01)

The effectiveness of adalimumab treatment for non-infectious uveitis
by: Eiichi Hasegawa, et al.
Published: (2019-04-01)

Profile of adalimumab and its potential in the treatment of uveitis
by: Balevic SJ, et al.
Published: (2016-09-01)

Complicações Imediatas de 3.555 aplicações de agentes anti-TNFα
by: Júlio César Bertacini de Moraes, et al.

Biological therapy in treatment of uveitis. Contemporary trends
by: A.V. Zborovskaia, et al.
Published: (2017-10-01)

Incidencia de tuberculosis en pacientes que reciben fármacos anti-TNFα
by: Ana Gruss, et al.
Published: (2020-03-01)

Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Biao Li, et al.
Published: (2021-04-01)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
by: Tomona Hiyama, et al.
Published: (2019-06-01)

Risk of Acute Anterior Uveitis in Ankylosing Spondylitis According to the Type of Tumor Necrosis Factor-Alpha Inhibitor and History of Uveitis: A Nationwide Population-Based Study
by: Soo Min Ahn, et al.
Published: (2022-01-01)

ANTI-CYTOKINE (ANTI-TNF-ALPHA) THERAPY IN OPHTHALMOLOGY (REVIEW OF LITERATURE)
by: N. A. Gavrilopva, et al.
Published: (2015-12-01)

Anti-cytokine (anti-TNF-alpha) therapy in ophthalmology (review of literature)
by: N.A. Gavrilopva, et al.
Published: (2013-02-01)

Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice
by: Maria Esposito, et al.
Published: (2019-07-01)

Behçet’s Disease Uveitis
by: Morgane Joubert, et al.
Published: (2023-05-01)

Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study
by: Aurore Dupont, et al.
Published: (2023-03-01)

Complicações Imediatas de 3.555 aplicações de agentes anti-TNFα Immediate complications of 3,555 injections of anti-TNFα
by: Júlio César Bertacini de Moraes, et al.
Published: (2010-04-01)

Adalimumab in Treating Refractory Livedoid Vasculopathy
by: Xiao-Wen Huang, et al.
Published: (2022-04-01)

Effects of anti-TNF biologic drugs on uveitis severity in Behcet patients: systematic review and Meta-analysis
by: Somayeh Abolhasani, et al.
Published: (2022-05-01)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
by: Loris Riccardo Lopetuso, et al.
Published: (2023-05-01)

Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis
by: Abdullah Sakkat, et al.
Published: (2022-03-01)

Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in Patients with Ulcerative Colitis
by: Atsushi Yoshida, et al.
Published: (2021-04-01)

Correlation of anti-TNF-a biological therapy with periodontal conditions and osteonecrosis in autoimmune patients: A systematic review
by: Rana Majdi Abunemer, et al.
Published: (2023-11-01)

Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa
by: Farida Benhadou, et al.
Published: (2018-01-01)

Evaluation of Therapeutic Drug Monitoring in the Clinical Management of Patients with Rheumatic Diseases: Data from a Retrospective Single-Center Cohort Study
by: Pedersen L, et al.
Published: (2020-10-01)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
by: Katarzyna Romanowska-Próchnicka, et al.
Published: (2021-03-01)

Adalimumab
by: Nilgun Atakan
Published: (2022-04-01)

Anti‐tumour necrosis factor‐α‐induced lupus in a patient receiving infliximab for sarcoidosis
by: Lachlan Stranks, et al.
Published: (2022-08-01)

Infliximab
by: İlgen Ertam Sağduyu
Published: (2022-04-01)

Successful Treatment of Severe Subcorneal Pustular Dermatosis with Adalimumab
by: Chen J, et al.
Published: (2022-11-01)

Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease
by: Albert Boronat-Toscano, et al.
Published: (2022-09-01)

Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
by: Tim van der Houwen, et al.
Published: (2020-04-01)

Protective Effect of Adalimumab on Diabetic Nephropathy by Regulating TNF-α Signal Pathway
by: Zhiying Ding, et al.
Published: (2021-11-01)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
by: Julie Gueudry, et al.
Published: (2021-05-01)

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
by: Zvonimir Petric, et al.
Published: (2022-08-01)

Uveitis occurring in a patient with psoriasis during adalimumab therapy: A case report
by: Qiaoli Zheng, et al.
Published: (2022-01-01)

Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)
by: Ligia Yukie Sassaki, et al.
Published: (2022-05-01)

Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn
by: Víctor Manuel Navas-López, et al.
Published: (2018-02-01)

Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
by: Jiaying Chen, et al.
Published: (2023-10-01)

Merkel cell carcinoma in a young female on infliximab
by: Alex Harrison, DO, et al.
Published: (2022-09-01)

Serum TNF-α and IL-1β levels in patients with RNFL thinning in uveitis complicated by optic nerve inflammation
by: M. V. Panchenko, et al.
Published: (2020-12-01)